Company Name: Libang Pharmaceutical Co., Ltd. - B conducts listing hearing on the Hong Kong Stock Exchange.

Liffermore Securities indicates that the submission of updated materials by Lee Pharma Limited-B after the hearing means that the company's IPO on the Hong Kong Stock Exchange has been approved.